Medicine and Dentistry
Esophageal Adenocarcinoma
100%
Neoadjuvant Chemotherapy
90%
Neoplasm
59%
Surgical Margin
54%
Hazard Ratio
49%
Recurrent Disease
48%
Esophagectomy
46%
Positron Emission Tomography-Computed Tomography
37%
Lymph Node
35%
Adenocarcinoma
33%
Abdominal Cancer
30%
Cancer Surgery
29%
Adjuvant Therapy
27%
Esophageal Cancer
23%
Odds Ratio
18%
Proportional Hazards Model
18%
Stomach Adenocarcinoma
17%
Quality of Life
16%
Adjuvant Chemotherapy
15%
Cancer
14%
Upper Gastrointestinal Cancer
13%
PET-MRI
13%
Esophagus
13%
Tomography
13%
Fluorodeoxyglucose
13%
Fluorodeoxyglucose F 18
13%
Endoscopic Ultrasound
13%
Surgical Anastomosis
13%
Ultrasound Computed Tomography
13%
Gastrointestinal Distress
13%
Preoperative Treatment
13%
Diseases
12%
Overall Survival
11%
Recurrence Risk
10%
Adjuvant Chemoradiotherapy
10%
Computer Assisted Tomography
9%
Primary Tumor
9%
Reflux
9%
Anastomosis Leakage
9%
Esophagus Anastomosis
9%
Stomach Surgery
9%
Stricture
9%
Recurrence Free Survival
8%
Mixed Tumor
7%
Tumor Regression
7%
Cohort Analysis
7%
Cancer Chemotherapy
6%
Lymphovascular Invasion
6%
Gastrectomy
6%
Metastatic Carcinoma
6%